Is Drugs Made In America Acquisition Corp. Ordinary Shares (DMAA) a Buy, Sell, or Hold?
NASDAQ : DMAA
Drugs Made In America Acquisition Corp. Ordinary Shares — Insider Trades
$10.7182 USD
$0.01 (0.08%)
- Volume
- 0.91
- Average Volume
- 36.51K
- Market Capitalization
- $361.39M
- P/E Ratio
- 52.39
- Dividend Yield
- 0.00%
- Price Target
- Year High
- $10.73
- Year Low
- $10.22
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.00
- Current Ratio
- $0.03
Insider Activity Summary (Last 12 Months)
Insiders Buying
12
Insiders Selling
4
Amount of Insider Selling
$12.2M
DMAA Insider Buying/Selling by Quarter
DMAA Insider Trading History
| Insider Name | Title | Date | Transaction | Cost | Filing Date |
|---|---|---|---|---|---|
| Drugs Made In America Acquisition LLC | 10 percent owner | 2025-02-18 | P-Purchase | 0 | 2025-02-18 |
| Drugs Made In America Acquisition LLC | 10 percent owner | 2025-02-18 | P-Purchase | 0 | 2025-02-18 |
| Stockwell Lynn | director, 10 percent owner, officer: CEO and Exe. Chair of Board | 2025-02-18 | P-Purchase | 0 | 2025-02-18 |
| Stockwell Lynn | director, 10 percent owner, officer: CEO and Exe. Chair of Board | 2025-02-18 | P-Purchase | 0 | 2025-02-18 |
| Drugs Made In America Acquisition LLC | 10 percent owner | 2025-01-29 | P-Purchase | 0 | 2025-02-04 |
| Drugs Made In America Acquisition LLC | 10 percent owner | 2025-01-29 | J-Other | 0 | 2025-02-04 |
| Drugs Made In America Acquisition LLC | 10 percent owner | 2025-01-29 | S-Sale | 1.5 | 2025-02-04 |
| Drugs Made In America Acquisition LLC | 10 percent owner | 2025-01-29 | P-Purchase | 0 | 2025-02-04 |
| Stockwell Lynn | director, 10 percent owner, officer: CEO and Executive COB | 2025-01-29 | J-Other | 0 | 2025-02-04 |
| Stockwell Lynn | director, 10 percent owner, officer: CEO and Executive COB | 2025-01-29 | S-Sale | 1.5 | 2025-02-04 |
| Stockwell Lynn | director, 10 percent owner, officer: CEO and Executive COB | 2025-01-29 | P-Purchase | 0 | 2025-02-04 |
| Stockwell Lynn | director, 10 percent owner, officer: CEO and Executive COB | 2025-01-29 | P-Purchase | 0 | 2025-02-04 |
| Shulgan Myron W. | director | 2025-01-29 | J-Other | 0 | 2025-02-03 |
| Prasad Sridhar G. | director | 2025-01-29 | J-Other | 0 | 2025-02-03 |
| Do Catherine | director | 2025-01-29 | J-Other | 0 | 2025-02-03 |
| Worman Glenn C. | officer: CFO | 2025-01-29 | J-Other | 0 | 2025-02-03 |
| Do Catherine | director: | 2025-01-07 | 0 | 2025-01-10 | |
| Prasad Sridhar G. | director: | 2025-01-07 | 0 | 2025-01-10 | |
| Drugs Made In America Acquisition LLC | 10 percent owner | 2025-01-07 | 0 | 2025-01-10 | |
| Stockwell Lynn | director, 10 percent owner, officer: See Remarks | 2025-01-07 | 0 | 2025-01-10 | |
| Shulgan Myron W. | director: | 2025-01-07 | 0 | 2025-01-10 | |
| Worman Glenn C. | officer | 2025-01-07 | 0 | 2025-01-10 |